We also treated CRC cells with autophagy activators (rapamycin) and autophagy inhibitors (3-methyladenine and bafilomycin A1), but there was no effect of autophagy modulation on the expression of FTO under hypoxia (Fig. S7C). This evidence concerns the gene FTO and colorectal carcinoma.